batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Boundless enthusiasm for CHK1 7 March 2024 AACR 2024 preview – more companies pile into popular mechanisms 6 March 2024 Gritstone investors get pre-Granite jitters 4 March 2024 Iovance’s lung cancer hold proves short lived 4 March 2024 Inhibrx cans co-stimulatory candidate 29 February 2024 No purple patch for Purple Biotech 28 February 2024 Legend investors hope EU endorsement is good omen 26 February 2024 After a long review tislelizumab makes EU progress 26 February 2024 Load More